Suppr超能文献

外分泌性胰腺肿瘤中嗜银核仁组织区计数

Argyrophilic nucleolar organizer region counts in exocrine pancreatic tumors.

作者信息

Ohta T, Nagakawa T, Tsukioka Y, Mori K, Kayahara M, Kanno M, Ueno K, Miyazaki I, Terada T, Nakanuma Y

机构信息

Department of Surgery (II), School of Medicine, Kanazawa University, Japan.

出版信息

Int J Pancreatol. 1992 Dec;12(3):201-9. doi: 10.1007/BF02924358.

Abstract

We enumerated the number of Ag-NORs in normal pancreatic ducts and exocrine pancreatic tumors to assess their cellular activity. Our results indicate that the mean number of Ag-NOR counts increased stepwise in the following order: normal pancreatic duct (1.26), serous cystadenoma (1.27), mucinous cystadenoma (1.65), mucinous cystadenocarcinoma (2.29), noninvasive intraductal variant of mucin-producing papillary adenocarcinoma (3.16), and a common type of invasive duct cell adenocarcinoma (3.78). These results suggest that cellular proliferative activity is low in normal pancreatic ducts and serous cystadenoma, intermediate in mucinous cystadenoma, and high in mucinous cystadenocarcinoma and duct cell adenocarcinoma. In addition, mucinous cystadenocarcinoma has significantly lower Ag-NOR counts than duct cell adenocarcinoma. We conclude that a clear quantitative difference between the Ag-NOR content of tumor cells of serous cystadenoma, mucinous cystadenoma, mucinous cystadenocarcinoma, and duct cell adenocarcinoma reflects the underlying different biologic behavior (chiefly, grade of malignancy) of these lesions.

摘要

我们对正常胰管和胰腺外分泌肿瘤中的银染核仁组织区(Ag-NORs)数量进行计数,以评估其细胞活性。我们的结果表明,Ag-NOR计数的平均数按以下顺序逐步增加:正常胰管(1.26)、浆液性囊腺瘤(1.27)、黏液性囊腺瘤(1.65)、黏液性囊腺癌(2.29)、产生黏液的乳头状腺癌的非侵袭性导管内变体(3.16)以及常见类型的侵袭性导管细胞腺癌(3.78)。这些结果表明,正常胰管和浆液性囊腺瘤中的细胞增殖活性较低,黏液性囊腺瘤中的活性中等,而黏液性囊腺癌和导管细胞腺癌中的活性较高。此外,黏液性囊腺癌的Ag-NOR计数明显低于导管细胞腺癌。我们得出结论,浆液性囊腺瘤、黏液性囊腺瘤、黏液性囊腺癌和导管细胞腺癌肿瘤细胞的Ag-NOR含量存在明显的定量差异,这反映了这些病变潜在的不同生物学行为(主要是恶性程度)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验